AGI-14100
Product Specifications
CAS Number
1448346-43-7
Target
Dehydrogenase|||Isocitrate Dehydrogenase (IDH)
Related Pathways
Metabolism
Purity
>99.99%
Bioactivity
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Smiles
N([C@H](C(NC1CC(F)(F)C1)=O)C2=C(Cl)C=CC=C2)(C(=O)[C@H]3N(C(=O)CC3)C4=CC(C#N)=CC=N4)C5=CC(F)=CC(F)=C5
Molecular Formula
C29H22ClF4N5O3
Molecular Weight
599.96
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6179535-01 0.1 mL
GREM1 (Gremlin 1, Cysteine Knot Superfamily, Homolog (Xenopus laevis), CKTSF1B1, DAND2, DRM, Gremlin, IHG-2, MGC126660, PIG2) (HRP)
Ask
View Details MBS6179535-02 5x 0.1 mL
GREM1 (Gremlin 1, Cysteine Knot Superfamily, Homolog (Xenopus laevis), CKTSF1B1, DAND2, DRM, Gremlin, IHG-2, MGC126660, PIG2) (HRP)
Ask
View Details MBS1450669-01 0.02 mg (E-Coli)
Recombinant Alcanivorax borkumensis Cobyric acid synthase (cobQ)
Ask
View Details 
MBS1450669-02 0.02 mg (Yeast)
Recombinant Alcanivorax borkumensis Cobyric acid synthase (cobQ)
Ask
View Details MBS1450669-03 0.1 mg (E-Coli)
Recombinant Alcanivorax borkumensis Cobyric acid synthase (cobQ)
Ask
View Details